Atique U Ahmed Selected Research

Atique U Ahmed Research Topics

Disease

31	Neoplasms (Cancer) 11/2022 - 12/2007
27	Glioma (Gliomas) 01/2022 - 01/2013
16	Glioblastoma (Glioblastoma Multiforme) 11/2022 - 01/2013
14	Brain Neoplasms (Brain Tumor) 01/2022 - 01/2012
7	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2015
4	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2015
4	Hypoxia (Hypoxemia) 01/2022 - 01/2014
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 12/2007
2	Infections 09/2011 - 03/2011
2	Carcinogenesis 11/2008 - 12/2007
1	Circulating Neoplastic Cells 12/2019
1	Virus Diseases (Viral Diseases) 07/2013
1	Hematologic Neoplasms (Hematological Malignancy) 07/2013
1	Lentivirus Infections 11/2008
1	Lung Neoplasms (Lung Cancer) 11/2008

Drug/Important Bio-Agent (IBA)

8	Temozolomide (Temodar)FDA LinkGeneric 11/2022 - 09/2013
6	Pharmaceutical PreparationsIBA 01/2022 - 03/2013
5	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 11/2008
3	PlasticsIBA 11/2022 - 10/2016
3	AntibodiesIBA 01/2022 - 11/2014
3	human ERBB2 proteinIBA 01/2022 - 10/2015
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2019
2	Trastuzumab (Herceptin)FDA Link 01/2022 - 10/2015
2	Fatty Acids (Saturated Fatty Acids)IBA 10/2020 - 01/2019
2	TubulinIBA 01/2020 - 05/2015
2	AntigensIBA 10/2018 - 03/2011
2	SurvivinIBA 01/2016 - 09/2015
2	Peptides (Polypeptides)IBA 09/2015 - 12/2014
2	AgarIBA 11/2008 - 12/2007
1	tucatinibIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	pertuzumabIBA 01/2022
1	olfactomedinIBA 01/2022
1	signal sequence receptorIBA 01/2022
1	taxaneIBA 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	purineIBA 01/2021
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2020
1	Single-Domain AntibodiesIBA 12/2019
1	Fatty Acid-Binding Protein 7IBA 01/2019
1	ChromatinIBA 01/2019
1	Dopamine (Intropin)FDA LinkGeneric 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	LipidsIBA 01/2019
1	MethyltransferasesIBA 01/2019
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2019
1	IntegrinsIBA 01/2019
1	Interleukin-8 (Interleukin 8)IBA 01/2019
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2019
1	Pyruvic Acid (Pyruvate)IBA 01/2019
1	OsteoprotegerinIBA 10/2016
1	ChemokinesIBA 10/2016
1	VaccinesIBA 07/2015
1	NestinIBA 05/2015
1	Antiviral Agents (Antivirals)IBA 02/2015
1	GD3 ganglioside (GD(3))IBA 12/2014
1	Contrast MediaIBA 12/2014
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2014
1	Trans-Activators (Trans-Acting Factor)IBA 12/2014
1	GoldIBA 12/2014
1	EnzymesIBA 01/2014
1	Heme Oxygenase-1IBA 01/2014
1	TNF-Related Apoptosis-Inducing LigandIBA 01/2014
1	Oxyquinoline (8 Hydroxyquinoline)FDA Link 01/2014
1	AntioxidantsIBA 11/2013
1	Sulfhydryl Compounds (Thiols)IBA 11/2013
1	N-AcetylcysteinamideIBA 11/2013
1	LigandsIBA 03/2013
1	CytokinesIBA 01/2013
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 11/2012
1	Chemotactic FactorsIBA 09/2011
1	Peptide Hydrolases (Proteases)FDA Link 11/2008
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 11/2008
1	Small Interfering RNA (siRNA)IBA 11/2008
1	Uridine Triphosphate (UTP)IBA 11/2008
1	ErbB Receptors (EGF Receptor)IBA 11/2008
1	Monomeric GTP-Binding ProteinsIBA 12/2007
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 12/2007

Therapy/Procedure

25	Therapeutics 11/2022 - 10/2010
10	Drug Therapy (Chemotherapy) 11/2022 - 09/2013
5	Oncolytic Virotherapy 01/2016 - 03/2010
4	Radiotherapy 11/2022 - 01/2012
1	Immunotherapy 11/2022
1	RNAi Therapeutics 01/2017
1	Biological Therapy 01/2016
1	Intravenous Administration 12/2014
1	Injections 11/2008